Search Results 571-580 of 18320 for peptides

  1. Publications - Elizabeth R. Vogel, M.D., Ph.D. - Mayo Clinic

    Caveolin-1 scaffolding domain peptide prevents hyperoxia-induced airway remodeling in a neonatal mouse model. Am J Physiol Lung Cell Mol Physiol. 2019 Jul 1 ...

  2. Cardiovascular Medicine - Doctors - Mayo Clinic

    Margaret M. Redfield, M.D.. Internist; Cardiologist. Rochester, MN. Areas of focus: Brain natriuretic peptide test, Heart failure, Cardiomyopathy, Pulmonary ...

  3. Atrial fibrillation - Doctors and departments - Mayo Clinic

    Jaffe, M.D.. Cardiologist; Internist. Rochester, MN. Areas of focus: Brain natriuretic peptide test, Troponin test, Fibrinogen test, Heart disease, Atrial ...

  4. Richard B. Kennedy, Ph.D. - Mayo Clinic Faculty Profiles

    ... Peptides into a Candidate Measles Vaccine, Mayo Clinic, 2014-2016; Editorial board, American Journal of Bioterrorism, Biosecurity and Biodefense, 2014 ...

  5. Clinical Trials - Statins for the Treatment of NASH

    inhibitors (gliptins) or glucagon-like peptide 1 analogs. 3. Immune modulatory agents including systemic steroids, methotrexate, anti-TNF-? therapies ...

  6. Untangling the threads of early-onset dementia - Mayo Clinic News Network

    In a related study, also published in Science Translational Medicine, Mayo Clinic researchers and collaborators discovered novel peptides in brain and ...

  7. Obesity - Diagnosis and treatment - Mayo Clinic

    Also approved by the FDA is a class of drugs known as glucagonlike peptide 1 agonists, also called GLP-1 agonists. Some of these medicines are approved ...

  8. Publications - Anna Svatikova, M.D., Ph.D. - Mayo Clinic

    Plasma brain natriuretic peptide in obstructive sleep apnea. Am J Cardiol. 2004 Aug 15; 94 (4):529-32. View PubMed; Svatikova A, Wolk R, Magera MJ ...

  9. A Study Comparing The Effectiveness And Safety Of The Morning Injection Of Toujeo Versus Lantus In Patients With Type 1 Diabetes Mellitus - Mayo Clinic

    Fasting c-peptide ≥0.3 nmol/L as per source document or central lab test at visit 1; Glycated hemoglobin (HbA1c) <7.0% or >9.0% via central lab test at ...

  10. A Study of Nighttime Blood Sugar Control Patterns in Type 2 Diabetes - Mayo Clinic

    Diabetics on insulin, glucagon-like peptide-1 based therapies or thiazolidinediones; Type 2 Diabetic subjects with microvascular or macrovascular ...